R-Pose
Natural health product licensed in Canada
- Licence holder
- Les Produits L.C.S. ELITE Products Inc.
- NPN or DIN-HM
- 80068523
- Status
- Active licence
- Licence date
- 14 April 2016
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
- Conditions légales
Trifolium pratense L.: La portion journalière recommandée ne doit pas conduire à une ingestion d'isoflavones supérieure à 1 mg/kg de poids corporel (exprimés comme aglycone du composant principal). L'étiquetage doit comporter un avertissement déconseillant l'usage chez les femmes ayant des antécédents personnels ou familiaux de cancer du sein.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
- Conditions légales
Medicago sativa L.: L'étiquetage doit comporter un avertissement déconseillant l'usage chez les femmes ayant des antécédents personnels ou familiaux de cancer du sein.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Eleutherococcus senticosus Source : Racine | 100 mg | Not calculated |
| Rhodymenia palmata Source : Thallus | 25 mg | Not calculated |
| Crataegus monogyna Source : Baie | 50 mg | Not calculated |
| Trifolium pratense Source : Fleur | 100 mg | Not calculated |
| Trifolium pratense Source : Feuille | 100 mg | Not calculated |
| Trifolium pratense Source : Tige(s) | 100 mg | Not calculated |
| Fucus Source : Thallus | 25 mg | Not calculated |
| Avena sativa Source : Feuille | 25 mg | Not calculated |
| Medicago sativa Source : Feuille | 50 mg | Not calculated |
| Rhodiola rosea Source : Racine Potency : 5 % Rosavines | 25 mg | Not calculated |
| Chondrus crispus Source : Thallus | 25 mg | Not calculated |
| Nasturtium officinale Source : Feuille | 25 mg | Not calculated |
| Prunus serotina Source : Écorce | 25 mg | Not calculated |
| Betula lenta Source : Écorce | 50 mg | Not calculated |
Non-medicinal ingredients
Stéarate de magnésium, Maltodextrine, Eau purifiée, Hypromellose
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 2 Capsule | 1 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Provides antioxidants.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80068523
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.